Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

For what it's worth...

I realize Braeburn has a lot of irons in the fire, but probuphine is their only approved drug.

Not including the $165 million in sales milestones and $35 million in chronic pain/other indication approval milestones, Titan receives roughly 1/5th of probuphine sales, without any deduction for the sales force, cost of production/manufacturing, overhead, commissions, marketing, speciality pharma distribution, training etc.

I think a really compelling case can be made that TTNP's market cap...on a strictly numbers basis...should equal at least 50% of Braeburn's. Hopefully some folks will wake up to that...